Mixed Results for Merck Blood Thinner
A second large study has revealed less than stellar results for an experimental Merck blood thinner. Researchers found that while it reduced cardiovascular events, it also increased the risk of major bleeding.
Aspirin Effective for PAD Patients
Patients with peripheral artery disease (PAD) appear to be able to improve their ability to walk without pain for longer periods when taking aspirin in conjunction with walking therapy.
Women With PAD Undertreated But Higher Risk
Peripheral artery disease (PAD) affects men and women nearly equally. Yet women are still more likely to go undiagnosed, even though the serious circulatory disease can nearly triple their risk of stroke and heart attack.
PAD Treatments Not Equal
Peripheral artery disease patients may not be receiving the same quality of care, and some may be paying more for similar treatment, depending on the type of provider.
Walk Your Heart to Health
Hold off on getting a stent if you suffer from peripheral artery disease (PAD). A simpler and less invasive supervised exercise program may better improve walking ability in patients with clogged blood vessels to the legs.
FDA Panel Green Lights New PAD Stent
A U.S. Food and Drug Administration panel has unanimously voted to approve the first drug-eluting stent developed to treat peripheral artery disease after deeming it both effective and safe.
UPDATE: AngioScore Balloon Catheter Recall
Information has been updated on AngioScore Incorporated's voluntary recall of their balloon catheters, due to bond failures that could result in death.